Hivid (Zalcitabine, ddC)

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Hivid (Zalcitabine, ddC)

See also: Drug Interactions | Medication Side Effects

Brand Name:	Hivid
Generic Name:	Zalcitabine, ddC
Adult Single Dose:	One 0.75-mg tablet (every 8 hours)
Food & Liquid Restrictions:	Take on an empty stomach
Drug Class:	NRTI

An Overview of Hivid (Zalcitabine, ddC) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
Zalcitabine (Hivid, ddC) (November 7, 2007)
To read PDF, click here
From AIDS InfoNet
ddC (Hivid) (August 15, 2006)
From AIDS Treatment Data Network
Hivid (Zalcitabine) (November 2005)
To read PDF, click here
From The Center for AIDS
Drug Interactions: Zalcitabine (August 2004)
From Project Inform
Patient Information About Hivid (Zalcitabine, ddC) (PDF) (September 2002)
From Roche

Our Mission and Team | Content Policy | Privacy Policy | Advertising and Sponsorship | Link to Us

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.